Your browser doesn't support javascript.
loading
Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures.
Galson, Jacob D; Schaetzle, Sebastian; Bashford-Rogers, Rachael J M; Raybould, Matthew I J; Kovaltsuk, Aleksandr; Kilpatrick, Gavin J; Minter, Ralph; Finch, Donna K; Dias, Jorge; James, Louisa K; Thomas, Gavin; Lee, Wing-Yiu Jason; Betley, Jason; Cavlan, Olivia; Leech, Alex; Deane, Charlotte M; Seoane, Joan; Caldas, Carlos; Pennington, Daniel J; Pfeffer, Paul; Osbourn, Jane.
Afiliación
  • Galson JD; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Schaetzle S; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Bashford-Rogers RJM; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Raybould MIJ; Wellcome Centre for Human Genetics, Oxford, United Kingdom.
  • Kovaltsuk A; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Kilpatrick GJ; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Minter R; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Finch DK; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Dias J; Alchemab Therapeutics Ltd, London, United Kingdom.
  • James LK; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Thomas G; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Lee WJ; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Betley J; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Cavlan O; Illumina, Inc., Illumina Centre, Cambridge, United Kingdom.
  • Leech A; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Deane CM; Alchemab Therapeutics Ltd, London, United Kingdom.
  • Seoane J; Oxford Protein Informatics Group, Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Caldas C; Translational Research Program, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Pennington DJ; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, United Kingdom.
  • Pfeffer P; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Osbourn J; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Front Immunol ; 11: 605170, 2020.
Article en En | MEDLINE | ID: mdl-33384691
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos B / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos B / Anticuerpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido